Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 2/20 | 0.52 |
| ▸ | PDGFRB | P09619 | 2/20 | 0.51 |
| ▸ | PDGFRA | P16234 | 2/20 | 0.51 |
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.47 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.46 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | ALKBH3 | Q96Q83 | 1/20 | 0.41 |
| ▸ | RORC | P51449 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12326161 | 0.91 | PDGFRB (0.58) | ACHEPDGFRBPDGFRAMAPTKDM4E | |
| SCHEMBL8264357 | 0.85 | KDM4E (0.54) | PDGFRBPDGFRAMAPTKDM4EALDH1A1 | |
| SCHEMBL14499448 | 0.85 | PDGFRB (0.50) | ACHEPDGFRBPDGFRAMAPTKDM4E | |
| SCHEMBL15342387 | 0.85 | DYRK1A (0.52) | ACHEPDGFRBPDGFRAMAPTKDM4E | |
| SCHEMBL1912033 | 0.85 | DYRK1A (0.52) | ACHEPDGFRBPDGFRAMAPTKDM4E | |
| SCHEMBL29644376 | 0.85 | KDM4E (0.54) | PDGFRBPDGFRAMAPTKDM4EALDH1A1 | |
| SCHEMBL12333997 | 0.84 | ACHE (0.67) | ACHEPDGFRBPDGFRAMAPTKDM4E | |
| SCHEMBL15342384 | 0.84 | PDGFRB (0.57) | ACHEPDGFRBPDGFRAMAPTKDM4E | |
| SCHEMBL8401018 | 0.84 | PDGFRB (0.53) | ACHEPDGFRBPDGFRAMAPTKDM4E | |
| SCHEMBL31042563 | 0.84 | ACHE (0.67) | ACHEPDGFRBPDGFRAMAPTKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020121979-A1 | LIQUID-CRYSTAL ALIGNMENT AGENT, LIQUID-CRYSTAL ALIGNMENT FILM, AND LIQUID-CRYSTAL DISPLAY ELEMENT | 日産化学株式会社 | 2020-06-18 | — | — | WO | disclosed |
| WO-2019189632-A1 | LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT | 日産化学株式会社 | 2019-10-03 | — | — | WO | disclosed |
| WO-2019181878-A1 | LIQUID CRYSTAL ALIGNING AGENT, LIQUID CRYSTAL ALIGNMENT FILM AND LIQUID CRYSTAL DISPLAY ELEMENT | 日産化学株式会社 | 2019-09-26 | — | — | WO | disclosed |
| US-20120232242-A1 | THIAZOLOTHIAZOLE COMPOUND AND THIAZOLOTHIAZOLE POLYMER | FUJI XEROX CO., LTD. (JP) | 2012-09-13 | — | — | US | disclosed |
| US-8264140-B2 | Organic electroluminescence element and display device | FUJI XEROX CO., LTD. (JP) | 2012-09-11 | — | — | US | disclosed |
| US-8264140-B2 | Organic electroluminescence element and display device | FUJI XEROX CO., LTD. (JP) | 2012-09-11 | — | — | US | disclosed |
| US-8207348-B2 | Thiazolothiazole compound and thiazolothiazole polymer | FUJI XEROX CO., LTD. (JP) | 2012-06-26 | — | — | US | disclosed |
| US-20110086999-A1 | THIAZOLOTHIAZOLE COMPOUND AND THIAZOLOTHIAZOLE POLYMER | FUJI XEROX CO., LTD. (JP) | 2011-04-14 | — | — | US | disclosed |
| US-7910748-B2 | Thiophene-containing compound and thiophene-containing compound polymer, organic electroluminescent device, production method thereof, and image display medium | FUJI XEROX CO., LTD. (JP) | 2011-03-22 | — | — | US | disclosed |
| US-7910748-B2 | Thiophene-containing compound and thiophene-containing compound polymer, organic electroluminescent device, production method thereof, and image display medium | FUJI XEROX CO., LTD. (JP) | 2011-03-22 | — | — | US | disclosed |
| US-7659410-B2 | Thiophene-containing compound and thiophene-containing compound polymer, organic electroluminescent device, production method thereof, and image display medium | FUJI XEROX CO., LTD. (JP) | 2010-02-09 | — | — | US | disclosed |
| WO-2009032249-A1 | SOLUBLE GUANYLATE CYCLASE ACTIVATORS | MERCK & CO., INC. (US) | 2009-03-12 | — | — | WO | disclosed |
| US-20090039774-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND DISPLAY DEVICE | FUJI XEROX CO., LTD. (JP) | 2009-02-12 | — | — | US | disclosed |
| US-20090039774-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND DISPLAY DEVICE | FUJI XEROX CO., LTD. (JP) | 2009-02-12 | — | — | US | disclosed |
| US-20080312453-A1 | Novel Carbazole Compound, and Polymer Thereof | FUJI XEROX CO., LTD. (JP) | 2008-12-18 | — | — | US | disclosed |
| US-20080312453-A1 | Novel Carbazole Compound, and Polymer Thereof | FUJI XEROX CO., LTD. (JP) | 2008-12-18 | — | — | US | disclosed |
| US-20070252519-A1 | Novel thiophene-containing compound and thiophene-containing compound polymer, organic electroluminescent device, production method thereof, and image display medium | FUJI XEROX CO., LTD. (JP) | 2007-11-01 | — | — | US | disclosed |
| US-20070252519-A1 | Novel thiophene-containing compound and thiophene-containing compound polymer, organic electroluminescent device, production method thereof, and image display medium | FUJI XEROX CO., LTD. (JP) | 2007-11-01 | — | — | US | disclosed |
| US-20070149570-A1 | Piperidine derivative and use thereof | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2007-06-28 | — | — | US | disclosed |
| WO-2004024060-A2 | METALLOPROTEINASE INHIBITORS AND INTERMEDIATES FOR PREPARATION THEREOF | ASTRAZENECA AB (SE) | 2004-03-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070149570-A1 | Piperidine derivative and use thereof | TACR1, OPRL1, TRPV1 | ACHE 1067/4885PDGFRB 239/4885PDGFRA 240/4885 |
| US-20080312453-A1 | Novel Carbazole Compound, and Polymer Thereof | ARL1, CDKL1, PARP11 | ACHE 3869/4885PDGFRB 1986/4885PDGFRA 2158/4885 |
| US-20070252519-A1 | Novel thiophene-containing compound and thiophene-containing compound polymer, organic electroluminescent device, production method thereof, and image display medium | ARL1, NOD1, NLRP1 | ACHE 3187/4885PDGFRB 3717/4885PDGFRA 4028/4885 |
| US-20110086999-A1 | THIAZOLOTHIAZOLE COMPOUND AND THIAZOLOTHIAZOLE POLYMER | ARL1, IRAK1, TYK2 | ACHE 4384/4885PDGFRB 1315/4885PDGFRA 1513/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.